13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Biology of Aging and Neurogenesis
Biology of Aging:
Aging can be defined as the time-related deterioration of the physiological functions compulsory, for survival and fertility.The characteristics of aging as distinguished from diseases of aging (such as cancer and heart disease) affect all the individuals of a species. Mortality can be used to define biological ageing, which refers to an organism's increased rate of death as it progresses throughout its lifecycle and increases its chronological age.
- The Neuroendocrine Theory
- The Free Radical Theory
- The Membrane Theory of Aging
- The Decline Theory
- The Cross-Linking Theory
Neurogenesis:
Neurogenesis is the process by which nervous system cells, the neurons, are produced by neural stem cells (NSCs). It take place in all species of animals except the porifera (sponges) and placozoans. Types of NSCs include neuroepithelial cells (NECs), radial glial cells (RGCs), basal progenitors (BPs), intermediate neuronal precursors (INPs), subventricular zone astrocytes, and subgranular zone radial astrocytes, among others.
- Developmental neurogenesis
- Adult neurogenesis
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States